Targeting progression and drug resistance in Triple Negative Breast Cancer
Targeting progression and drug resistance in Triple Negative Breast Cancer
Targeting progression and drug resistance in Triple Negative Breast Cancer
Targeting progression and drug resistance in Triple Negative Breast Cancer
Nandini Verma, Department of Molecular Cell Biology Weizmann Institutr of Science, Israel
23-01-2018 08:30:00
